Bioorganic and Medicinal Chemistry p. 3464 - 3471 (2016)
Update date:2022-08-05
Topics:
Ofori, Edward
Zhu, Xue Y.
Etukala, Jagan R.
Peprah, Kwakye
Jordan, Kamanski R.
Adkins, Adia A.
Bricker, Barbara A.
Kang, Hye J.
Huang, Xi-Ping
Roth, Bryan L.
Ablordeppey, Seth Y.
5-HT1Aand 5-HT7receptors have been at the center of discussions recently due in part to their major role in the etiology of major central nervous system diseases such as depression, sleep disorders, and schizophrenia. As part of our search to identify dual targeting ligands for these receptors, we have carried out a systematic modification of a selective 5HT7receptor ligand culminating in the identification of several dual 5-HT1Aand 5-HT7receptor ligands. Compound 16, a butyrophenone derivative of tetrahydroisoquinoline (THIQ), was identified as the most potent agent with low nanomolar binding affinities to both receptors. Interestingly, compound 16 also displayed moderate affinity to other clinically relevant dopamine receptors. Thus, it is anticipated that compound 16 may serve as a lead for further exploitation in our quest to identify new ligands with the potential to treat diseases of CNS origin.
View MoreChangzhou BaoKang Pharmaceutical & Chemical Co., Ltd
Contact:(86) 519-88782201 88784080 88785278
Address:Henglin town, changzhou,Jiangsu
Huangshi Meifeng Chemical Co.,ltd.
Contact:+86-714-6516706
Address:1941-4-3#,Hubin Avenue,Huangshi,Hubei,China
He Bei Shun Er Chemical Co., LTD.
Contact:86-0311-86996932/86860168
Address:No 18,North street
Dongtai Xinyuan Chemical Co., Ltd.
Contact:+86-21-56733000
Address:404F, 99Nong No.117 Zhongtan Rd. Shanghai
Tianjin Derchemist Sci-Tech Co., Ltd.
website:http://www.derchemist.com
Contact:+86-22-58627059
Address:Xinmao Science and Technology Park,Huayuan Industrial Park
Doi:10.1021/ol501246f
(2014)Doi:10.1002/anie.201310491
(2014)Doi:10.1002/ejoc.201402852
(2014)Doi:10.1016/j.ejmech.2014.04.076
(2014)Doi:10.1021/ol501465x
(2014)Doi:10.1002/cmdc.202100273
(2021)